Elena Qirjazi1,2, Fabio R Salerno1,3, Alireza Akbari3,4, Lisa Hur1,3, Jarrin Penny1,3, Timothy Scholl1,4, Christopher W McIntyre1,3. 1. Department of Medical Biophysics, Western University, London, Ontario, Canada. 2. Alberta Health Services, Calgary, Alberta, Canada. 3. Lilibeth Caberto Kidney Clinical Research Unit, London Health Sciences Centre, London, Ontario, Canada. 4. Robarts Research Institute, Western University, London, Ontario, Canada.
Abstract
BACKGROUND: Sodium-23 magnetic resonance imaging (23Na MRI) allows direct measurement of tissue sodium concentrations. Current knowledge of skin, muscle and bone sodium concentrations in chronic kidney disease (CKD) and renal replacement therapy patients is limited. In this study we measured the tissue sodium concentrations in CKD, hemodialysis (HD) and peritoneal dialysis (PD) patients with 23Na MRI of the lower leg and explored their correlations with established clinical biomarkers. METHODS: Ten healthy controls, 12 CKD Stages 3-5, 13 HD and 10 PD patients underwent proton and 23Na MRI of the leg. The skin, soleus and tibia were segmented manually and tissue sodium concentrations were measured. Plasma and serum samples were collected from each subject and analyzed for routine clinical biomarkers. Tissue sodium concentrations were compared between groups and correlations with blood-based biomarkers were explored. RESULTS: Tissue sodium concentrations in the skin, soleus and tibia were higher in HD and PD patients compared with controls. Serum albumin showed a strong, negative correlation with soleus sodium concentrations in HD patients (r = -0.81, P < 0.01). Estimated glomerular filtration rate showed a negative correlation with tissue sodium concentrations (soleus: r = -0.58, P < 0.01; tibia: r = -0.53, P = 0.01) in merged control-CKD patients. Hemoglobin was negatively correlated with tissue sodium concentrations in CKD (soleus: r = -0.65, P = 0.02; tibia: r = -0.73, P < 0.01) and HD (skin: r = -0.60, P = 0.04; tibia: r = -0.76, P < 0.01). CONCLUSION: Tissue sodium concentrations, measured by 23Na MRI, increase in HD and PD patients and may be associated with adverse metabolic effects in CKD and dialysis.
BACKGROUND:Sodium-23 magnetic resonance imaging (23Na MRI) allows direct measurement of tissue sodium concentrations. Current knowledge of skin, muscle and bone sodium concentrations in chronic kidney disease (CKD) and renal replacement therapy patients is limited. In this study we measured the tissue sodium concentrations in CKD, hemodialysis (HD) and peritoneal dialysis (PD) patients with 23Na MRI of the lower leg and explored their correlations with established clinical biomarkers. METHODS: Ten healthy controls, 12 CKD Stages 3-5, 13 HD and 10 PD patients underwent proton and 23Na MRI of the leg. The skin, soleus and tibia were segmented manually and tissue sodium concentrations were measured. Plasma and serum samples were collected from each subject and analyzed for routine clinical biomarkers. Tissue sodium concentrations were compared between groups and correlations with blood-based biomarkers were explored. RESULTS: Tissue sodium concentrations in the skin, soleus and tibia were higher in HD and PD patients compared with controls. Serum albumin showed a strong, negative correlation with soleus sodium concentrations in HD patients (r = -0.81, P < 0.01). Estimated glomerular filtration rate showed a negative correlation with tissue sodium concentrations (soleus: r = -0.58, P < 0.01; tibia: r = -0.53, P = 0.01) in merged control-CKDpatients. Hemoglobin was negatively correlated with tissue sodium concentrations in CKD (soleus: r = -0.65, P = 0.02; tibia: r = -0.73, P < 0.01) and HD (skin: r = -0.60, P = 0.04; tibia: r = -0.76, P < 0.01). CONCLUSION: Tissue sodium concentrations, measured by 23Na MRI, increase in HD and PD patients and may be associated with adverse metabolic effects in CKD and dialysis.
Authors: Guido Filler; Clara Schott; Fabio Rosario Salerno; Andrea Ens; Christopher William McIntyre; Maria Esther Díaz González de Ferris; Robert Stein Journal: Bone Rep Date: 2022-05-18
Authors: Konstantin Huhn; Peter Linz; Franziska Pemsel; Bernhard Michalke; Stefan Seyferth; Christoph Kopp; Mohammad Anwar Chaudri; Veit Rothhammer; Arnd Dörfler; Michael Uder; Armin M Nagel; Dominik N Müller; Anne Waschbisch; De-Hyung Lee; Tobias Bäuerle; Ralf A Linker; Stefanie Haase Journal: Proc Natl Acad Sci U S A Date: 2021-07-13 Impact factor: 11.205
Authors: Melis Sahinoz; Supisara Tintara; Serpil Muge Deger; Aseel Alsouqi; Rachelle L Crescenzi; Cindy Mambungu; Andrew Vincz; Olivia Mason; Heather L Prigmore; Andrew Guide; Thomas G Stewart; David Harrison; Friedrich C Luft; Jens Titze; T Alp Ikizler Journal: Nephrol Dial Transplant Date: 2020-12-22 Impact factor: 5.992
Authors: Aseel Alsouqi; Serpil Muge Deger; Melis Sahinoz; Cindy Mambungu; Adrienne R Clagett; Aihua Bian; Andrew Guide; Thomas G Stewart; Mindy Pike; Cassianne Robinson-Cohen; Rachelle Crescenzi; Meena S Madhur; David G Harrison; Talat Alp Ikizler Journal: J Am Heart Assoc Date: 2022-04-18 Impact factor: 6.106
Authors: Anke Dahlmann; Peter Linz; Isabelle Zucker; Viktor Haag; Jonathan Jantsch; Thomas Dienemann; Armin M Nagel; Patrick Neubert; Daniela Rosenhauer; Manfred Rauh; Stephan Horn; Dominik N Müller; Mario Schiffer; Friedrich C Luft; Michael Uder; Christoph Kopp Journal: Kidney Int Rep Date: 2021-06-28